Oorsprong van het eerstegraads netwerk van Masanori Tsuno
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 52 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Masanori Tsuno via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| STANDEX INTERNATIONAL CORPORATION | Electronic Equipment/Instruments | Director of Finance/CFO | |
| Veranova LP | Corporate Officer/Principal | ||
| H. LUNDBECK A/S | Pharmaceuticals: Major | Director/Board Member | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| MARINUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| MERSANA THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
| IPSEN | Pharmaceuticals: Major | Human Resources Officer | |
| Thunderbird School of Global Management | College/University | Graduate Degree | |
Eisai Ltd. (United Kingdom)
 Eisai Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Eisai Ltd. (United Kingdom) is a pharmaceutical company based in Hatfield, UK. Part of Eisai Co., Ltd., Eisai Ltd. prioritizes patients and their families by continually improving the benefits that healthcare can provide. The British company was founded in 1988 and Gary Bryan Hendler has been the CEO of the company since 2008. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| PENTAIR PLC | Industrial Machinery | Comptroller/Controller/Auditor | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree | |
Eisai SAS
 Eisai SAS Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai SAS is a French pharmaceutical company founded in 1996. The company is based in Courbevoie, France and strives to improve the lives of those who could benefit from their medicines. Eisai focuses its research on oncology and neurology, two areas presenting challenges in terms of public health. The company is committed to the fight against serious diseases, alongside patients, healthcare professionals, and public authorities. | Pharmaceuticals: Major | Chairman | |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Pharmaceuticals: Major | Chief Executive Officer Chairman Chief Executive Officer Chief Executive Officer Corporate Officer/Principal Chief Executive Officer | |
| Brandeis University | College/University | Doctorate Degree | |
| Lycoming College | College/University | Undergraduate Degree | |
| University of Bridgeport | College/University | Undergraduate Degree | |
| Quinnipiac University | College/University | Undergraduate Degree | |
| University of Massachusetts | College/University | Graduate Degree | |
| INOVIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Barcelona | College/University | Doctorate Degree | |
| University of Hitotsubashi | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| The Medical College of Wisconsin, Inc. | College/University | Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member | |
| Universidad Autónoma de Madrid | College/University | Doctorate Degree | |
Sunplanet Co., Ltd.
 Sunplanet Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Eisai Co., Ltd., Sunplanet Co., Ltd. is a Japanese company that provides facility management, pharmaceutical analysis, and research development services. The company is based in Tokyo, Japan and was founded in 2001. | Miscellaneous Commercial Services | President Director/Board Member President Director/Board Member | |
| BICYCLE THERAPEUTICS PLC | Biotechnology | Corporate Officer/Principal | |
EA Pharma Co., Ltd.
 EA Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., EA Pharma Co., Ltd. is a specialty pharmaceutical company based in Tokyo, Japan. The Japanese company specializes in digestive diseases such as inflammatory intestinal diseases and focuses on advanced research and development and marketing activities to solve unmet medical needs. EA Pharma Co. provides drug discovery research, development research related to gastrointestinal diseases, and drug discovery base technology research to meet the further medical needs of patients. The company's production department aims to create products that have effective and safety as a drug and ensure the quality of the product. EA Pharma Co. aims to be the largest digestive pharmacy in Japan, which was born in the integration of the digestive business of the Eisai group and the Ajinomoto group's digestive business. | Pharmaceuticals: Major | Director/Board Member President | |
Eisai Farmacéutica SA
 Eisai Farmacéutica SA Pharmaceuticals: MajorHealth Technology Eisai Farmacéutica SA is a pharmaceutical company based in Madrid, Spain. Eisai Farmacéutica SA operates as a Spanish pharmaceutical company. Part of Eisai Co., Ltd., the company was founded in 2001. The CEO is Gary Bryan Hendler. | Pharmaceuticals: Major | Chief Executive Officer | |
Eisai R&D Management Co., Ltd.
 Eisai R&D Management Co., Ltd. BiotechnologyHealth Technology Part of Eisai Co., Ltd., Eisai R&D Management Co., Ltd. engages in research and development of pharmaceuticals. The company is based in Bunkyo, Japan. | Biotechnology | President President | |
H3 Biomedicine, Inc.
 H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chief Executive Officer | |
Hospital Clínic de Barcelona
 Hospital Clínic de Barcelona Hospital/Nursing ManagementHealth Services Hospital Clínic de Barcelona is a healthcare company based in Barcelona, Spain. The Spanish company operates a website for Hospital Clínic and IDIBAPS. The CEO of the private company is Josep Maria Campistol. | Hospital/Nursing Management | Corporate Officer/Principal | |
| PUMA BIOTECHNOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member | |
Japanese Chamber of Commerce & Industry of New York, Inc.
 Japanese Chamber of Commerce & Industry of New York, Inc. Miscellaneous Commercial ServicesCommercial Services Japanese Chamber of Commerce Industry of New York, Inc. is non-profit organization that engages in facilitation of trade between the U.S. and Japan. The company was founded on November 14, 1932 by 14 prominent Japanese businessman, and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
| Drexel University College of Medicine | College/University | Doctorate Degree | |
| Harvard Business School | College/University | Masters Business Admin | |
| Duke University School of Medicine | College/University | Doctorate Degree | |
StandexMeder Electronics GmbH
 StandexMeder Electronics GmbH Electrical ProductsProducer Manufacturing Part of Standex International Corp., StandexMeder Electronics GmbH designs, manufactures and markets reed switches, relays, sensors and other products. The company is based in Singen, Germany. The CEOs of the German company are John Meeks, Ademir Sarcevic, Rainer Hombeck. | Electrical Products | Chief Executive Officer | |
Boston Pharmaceuticals, Inc.
 Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| FULCRUM THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Nextpoint Therapeutics, Inc.
 Nextpoint Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nextpoint Therapeutics, Inc. is a biotech company based in Cambridge, MA. The company is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. The company's innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. Nextpoint Therapeutics has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class immunotherapies. Detlev Biniszkiewicz has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Chief Executive Officer | |
GlycoEra AG
 GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | Biotechnology | Director/Board Member | |
| ALLENA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Eisai Manufacturing Ltd.
 Eisai Manufacturing Ltd. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai Manufacturing Ltd. is a pharmaceutical company based in Hatfield, UK. The British company's focus is on developing new medicines for neglected tropical diseases and malaria, improving access to medicines for non-communicable diseases, and promoting sustainability. Eisai Manufacturing is committed to funding the 3rd phase of health innovative technology fund activities. The company's official corporate website provides information on their initiatives and HHC concept. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 32 |
| Verenigd Koninkrijk | 5 |
| Spanje | 5 |
| Japan | 5 |
| Frankrijk | 4 |
Sectoraal
| Health Technology | 27 |
| Consumer Services | 15 |
| Commercial Services | 6 |
| Producer Manufacturing | 3 |
| Electronic Technology | 2 |
Operationeel
| Corporate Officer/Principal | 62 |
| Director/Board Member | 58 |
| Independent Dir/Board Member | 18 |
| Chief Executive Officer | 13 |
| President | 11 |
Sterkste connecties
- Beurs
- Insiders
- Masanori Tsuno
- Bedrijfsconnecties
